Based on your language, we suggest to change your settings to: En fonction de votre langue, nous vous suggérons de modifier vos paramètres comme suit :
Yes, that's correct Oui, c'est correct.
An Award-Winning Innovation in Drug-Free Airway Clearance Therapy.
Buy online or submit this form to your doctor.
Looking for a resource to help better manage your condition?
Could you be reimbursed for your purchase?
A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease Patients Managed with the Aerobika* device.
Evaluates daily use of an OPEP device for 21–28 days in COPD patients who were self-identified as sputum-producers or non-sputum-producers.
Quality of Life Responder Rate Analysis Following Use of an Oscillating Positive Expiratory Pressure Device for Chronic Obstructive Pulmonary Disease.
References:
1. Sugget J. Quality of life responder rate analysis; SGRQ vs CAT assessment. COPD 10, 2016. UK.
2. Coppolo DP, et al. Plum Ther. 2022 Mar 8: (1): 1-41.
3. Harkness H, et al. Canadian Respiratory Journal. 2015;22(Suppl A):10A-11A.
4. O’Donnell DE, et al. Thorax 2006;61:354-361